← Sika overview

Sika vs Axalta Coating Systems: why the prices moved differently

Weekly · monthly · quarterly news summaries, side by side in time

Sika AG (SIKA.SW)

Q3 2026
▲4

Sika lifts guidance, buys two firms, and cuts debt cost

  • Guidance raised on strong first half Sika lifted its 2026 sales growth outlook to 3-6% from 1-4% after first-half sales rose 4% in local currencies and profit margin edged up. A higher growth target tells investors the business is doing better than expected, which supports the share price.

    A guidance upgrade is the single biggest new signal about Sika's underlying business momentum.

  • Cheaper funding and a stable credit rating Sika sold its first hybrid bond, raising EUR 1 billion at around 4.4-4.9% interest, and S&P improved its rating outlook to Stable. This lowers Sika's borrowing costs and gives it money for small acquisitions without selling more shares.

    The bond and rating change directly affect Sika's cost of capital and ability to fund growth.

  • Two acquisitions expand adhesives and UK reach Sika closed the purchase of Turkish adhesives maker Akkim (about CHF 220 million of sales) and bought UK landscaping products firm Azpects. Both add products and distribution, with management aiming to double Akkim's sales in five years and expecting cost savings.

    These deals are new growth and synergy drivers that add sales and profit over time.

  • Cost savings and analyst upgrade support earnings At its investor day Sika said its Fast Forward cost-cutting program will save CHF 80 million in 2026 and CHF 150-200 million by 2028. Separately, Zacks upgraded the ADR to Buy as earnings estimates rose. Both point to higher future profits.

    Cost savings and rising analyst estimates are concrete supports for future earnings and the share price.

September 2026
▲4

Sika lifts guidance, buys two firms, and cuts debt cost

  • Guidance raised on strong first half Sika lifted its 2026 sales growth outlook to 3-6% from 1-4% after first-half sales rose 4% in local currencies and profit margin edged up. A higher growth target tells investors the business is doing better than expected, which supports the share price.

    A guidance upgrade is the single biggest new signal about Sika's underlying business momentum.

  • Cheaper funding and a stable credit rating Sika sold its first hybrid bond, raising EUR 1 billion at around 4.4-4.9% interest, and S&P improved its rating outlook to Stable. This lowers Sika's borrowing costs and gives it money for small acquisitions without selling more shares.

    The bond and rating change directly affect Sika's cost of capital and ability to fund growth.

  • Two acquisitions expand adhesives and UK reach Sika closed the purchase of Turkish adhesives maker Akkim (about CHF 220 million of sales) and bought UK landscaping products firm Azpects. Both add products and distribution, with management aiming to double Akkim's sales in five years and expecting cost savings.

    These deals are new growth and synergy drivers that add sales and profit over time.

  • Cost savings and analyst upgrade support earnings At its investor day Sika said its Fast Forward cost-cutting program will save CHF 80 million in 2026 and CHF 150-200 million by 2028. Separately, Zacks upgraded the ADR to Buy as earnings estimates rose. Both point to higher future profits.

    Cost savings and rising analyst estimates are concrete supports for future earnings and the share price.

Latest
▲4

Sika lifts guidance, buys two firms, and cuts debt cost

  • Guidance raised on strong first half Sika lifted its 2026 sales growth outlook to 3-6% from 1-4% after first-half sales rose 4% in local currencies and profit margin edged up. A higher growth target tells investors the business is doing better than expected, which supports the share price.

    A guidance upgrade is the single biggest new signal about Sika's underlying business momentum.

  • Cheaper funding and a stable credit rating Sika sold its first hybrid bond, raising EUR 1 billion at around 4.4-4.9% interest, and S&P improved its rating outlook to Stable. This lowers Sika's borrowing costs and gives it money for small acquisitions without selling more shares.

    The bond and rating change directly affect Sika's cost of capital and ability to fund growth.

  • Two acquisitions expand adhesives and UK reach Sika closed the purchase of Turkish adhesives maker Akkim (about CHF 220 million of sales) and bought UK landscaping products firm Azpects. Both add products and distribution, with management aiming to double Akkim's sales in five years and expecting cost savings.

    These deals are new growth and synergy drivers that add sales and profit over time.

  • Cost savings and analyst upgrade support earnings At its investor day Sika said its Fast Forward cost-cutting program will save CHF 80 million in 2026 and CHF 150-200 million by 2028. Separately, Zacks upgraded the ADR to Buy as earnings estimates rose. Both point to higher future profits.

    Cost savings and rising analyst estimates are concrete supports for future earnings and the share price.

Axalta Coating Systems Ltd (AXTA)

Q3 2026
▲3

Axalta's Akzo merger clears EU hurdle as earnings stay strong

  • EU regulators set to clear Akzo deal with divestments AkzoNobel will sell overlapping vehicle-refinish businesses to satisfy EU regulators, who are expected to approve the $25 billion all-stock merger; the powder-coating concern was dropped. Removing this regulatory block makes the deal far more likely to close, supporting AXTA's price.

    This is the biggest new force: the merger's key regulatory hurdle is being cleared.

  • Q2 beat: record EBITDA, revenue and EPS above estimates Axalta posted record quarterly adjusted EBITDA of $305 million at a 22.7% margin, revenue up 3.1% to $1.35 billion and EPS of $0.72, both beating estimates, with Refinish and Mobility growing. Strong results and maintained guidance support the stock.

    The quarter's results are the core fundamental driver behind the shares.

  • Governance sweeteners and Akzo's own profit growth After shareholder talks, the combined company will hold annual director elections and lower a key approval threshold to two-thirds. AkzoNobel also reported higher Q2 profit and said the merger is on track, with a shareholder vote set for August 5.

    These steps reduce deal risk and show the partner is financially healthy.

  • Fairness probe and valuation debate temper the good news A law firm is investigating whether Axalta's shareholders get a fair deal, which could pressure terms. Meanwhile one valuation model calls the stock about 30% overvalued near $35.81, while a cash-flow model sees it far higher, so views on worth are split.

    This is the real counterweight: legal risk to the deal and disagreement over what the shares are worth.

August 2026
▲3

Axalta's Akzo merger clears EU hurdle as earnings stay strong

  • EU regulators set to clear Akzo deal with divestments AkzoNobel will sell overlapping vehicle-refinish businesses to satisfy EU regulators, who are expected to approve the $25 billion all-stock merger; the powder-coating concern was dropped. Removing this regulatory block makes the deal far more likely to close, supporting AXTA's price.

    This is the biggest new force: the merger's key regulatory hurdle is being cleared.

  • Q2 beat: record EBITDA, revenue and EPS above estimates Axalta posted record quarterly adjusted EBITDA of $305 million at a 22.7% margin, revenue up 3.1% to $1.35 billion and EPS of $0.72, both beating estimates, with Refinish and Mobility growing. Strong results and maintained guidance support the stock.

    The quarter's results are the core fundamental driver behind the shares.

  • Governance sweeteners and Akzo's own profit growth After shareholder talks, the combined company will hold annual director elections and lower a key approval threshold to two-thirds. AkzoNobel also reported higher Q2 profit and said the merger is on track, with a shareholder vote set for August 5.

    These steps reduce deal risk and show the partner is financially healthy.

  • Fairness probe and valuation debate temper the good news A law firm is investigating whether Axalta's shareholders get a fair deal, which could pressure terms. Meanwhile one valuation model calls the stock about 30% overvalued near $35.81, while a cash-flow model sees it far higher, so views on worth are split.

    This is the real counterweight: legal risk to the deal and disagreement over what the shares are worth.

Latest
▲3

Axalta's Akzo merger clears EU hurdle as earnings stay strong

  • EU regulators set to clear Akzo deal with divestments AkzoNobel will sell overlapping vehicle-refinish businesses to satisfy EU regulators, who are expected to approve the $25 billion all-stock merger; the powder-coating concern was dropped. Removing this regulatory block makes the deal far more likely to close, supporting AXTA's price.

    This is the biggest new force: the merger's key regulatory hurdle is being cleared.

  • Q2 beat: record EBITDA, revenue and EPS above estimates Axalta posted record quarterly adjusted EBITDA of $305 million at a 22.7% margin, revenue up 3.1% to $1.35 billion and EPS of $0.72, both beating estimates, with Refinish and Mobility growing. Strong results and maintained guidance support the stock.

    The quarter's results are the core fundamental driver behind the shares.

  • Governance sweeteners and Akzo's own profit growth After shareholder talks, the combined company will hold annual director elections and lower a key approval threshold to two-thirds. AkzoNobel also reported higher Q2 profit and said the merger is on track, with a shareholder vote set for August 5.

    These steps reduce deal risk and show the partner is financially healthy.

  • Fairness probe and valuation debate temper the good news A law firm is investigating whether Axalta's shareholders get a fair deal, which could pressure terms. Meanwhile one valuation model calls the stock about 30% overvalued near $35.81, while a cash-flow model sees it far higher, so views on worth are split.

    This is the real counterweight: legal risk to the deal and disagreement over what the shares are worth.